Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7
N. R. Chu, H. B. Wu, T. C. Wu, L. J. Boux, L. A. Mizzen, M. I. Siegel
Dive into the research topics of 'Immunotherapy of a human papillomavirus type 16 E7-expressing tumor by administration of fusion protein comprised of Mycobacterium bovis BCG Hsp65 and HPV16 E7'. Together they form a unique fingerprint.